Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial. - De Caluwé A; Desmoulins I; Cao K; Remouchamps V; Baten A; Longton E; Peignaux K; Joaquin Garcia A; Venet D; Arecco L; Agostinetto E; Nader-Marta G; et al. (Nature medicine, 2026)